Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Elliott

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
European Journal of Haematology|March 25, 2010
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic considerationMichelle A Elliott, Louis Letendre, Dennis A Gastineau, et al.
Mayo Clinic Proceedings|July 13, 2005
"Myelodysplasia," myeloneuropathy, and copper deficiencyNeeraj Kumar, Michelle A Elliott, James D Hoyer, et al.
Mayo Clinic Proceedings|June 13, 2016
Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision MedicineMalik Nassan, Wayne T Nicholson, Michelle A Elliott, et al.
Blood Cancer Journal|February 17, 2018
CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survivalNatasha Szuber, Christy M Finke, Terra L Lasho, et al.
American Journal of Hematology|April 9, 2015
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemiaMichelle A Elliott, Animesh Pardanani, Curtis A Hanson, et al.
Journal of Clinical Apheresis|September 18, 2014
Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplantSudhanshu Mulay, Justin D Kreuter, Sandra C Bryant, et al.
Cancer|March 15, 2006
Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapyAyalew Tefferi, Jacob J Strand, Terra L Lasho, et al.
Blood|October 3, 2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalMichelle A Elliott, Mark R Litzow, Louis L Letendre, et al.
American Journal of Hematology|January 11, 2022
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experienceFaiqa Farrukh, Naseema Gangat, Mithun V Shah, et al.
British Journal of Haematology|April 26, 2002
Thalidomide treatment in myelofibrosis with myeloid metaplasiaMichelle A Elliott, Ruben A Mesa, Chin-Yang Li, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Haematology|March 25, 2010
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic considerationMichelle A Elliott, Louis Letendre, Dennis A Gastineau, et al.
Mayo Clinic Proceedings|July 13, 2005
"Myelodysplasia," myeloneuropathy, and copper deficiencyNeeraj Kumar, Michelle A Elliott, James D Hoyer, et al.
Mayo Clinic Proceedings|June 13, 2016
Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision MedicineMalik Nassan, Wayne T Nicholson, Michelle A Elliott, et al.
Blood Cancer Journal|February 17, 2018
CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survivalNatasha Szuber, Christy M Finke, Terra L Lasho, et al.
American Journal of Hematology|April 9, 2015
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemiaMichelle A Elliott, Animesh Pardanani, Curtis A Hanson, et al.
Journal of Clinical Apheresis|September 18, 2014
Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplantSudhanshu Mulay, Justin D Kreuter, Sandra C Bryant, et al.
Cancer|March 15, 2006
Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapyAyalew Tefferi, Jacob J Strand, Terra L Lasho, et al.
Blood|October 3, 2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalMichelle A Elliott, Mark R Litzow, Louis L Letendre, et al.
American Journal of Hematology|January 11, 2022
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experienceFaiqa Farrukh, Naseema Gangat, Mithun V Shah, et al.
British Journal of Haematology|April 26, 2002
Thalidomide treatment in myelofibrosis with myeloid metaplasiaMichelle A Elliott, Ruben A Mesa, Chin-Yang Li, et al.
Pageof 9